This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Jeiji Kaneda: Innovator in Antibiotic Development
Introduction
Jeiji Kaneda is a prominent inventor based in Aichi, Japan. He is known for his significant contributions to the field of microbiology and antibiotic development. His work has led to the creation of valuable new substances that have the potential to impact healthcare positively.
Latest Patents
Kaneda holds a patent for N-Demethylefrotomycin, a novel antibiotic substance. This antibiotic is produced through the microbial conversion of mocimycin using a unique microbial species, ATCC 53758. His innovative approach in this area showcases his dedication to advancing medical science.
Career Highlights
Kaneda is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with other experts in the field and contribute to groundbreaking research and development in antibiotics.
Collaborations
Throughout his career, Kaneda has worked alongside notable colleagues, including Martin R. Jefson and Satoshi Nishiyama. These collaborations have enriched his research and have been instrumental in the development of new antibiotic therapies.
Conclusion
Jeiji Kaneda's work in antibiotic development exemplifies the importance of innovation in healthcare. His contributions, particularly in the creation of N-Demethylefrotomycin, highlight the potential for new treatments that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile